Steven Prestrelski - 05 Oct 2021 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role: Chief Scientific Officer
Signature: /s/ Beth Hecht, as Attorney-in-Fact
Issuer symbol: XERS
Transactions as of: 05 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 05 Oct 2021, 17:16:47 UTC
Next filing: 05 Jan 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney